Drug Type Immunoglobulin |
Synonyms- |
Target |
Mechanism Immunoglobulin agonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (31 Dec 1997), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
IgG Deficiency | CN | 31 Dec 1997 | |
Mucocutaneous Lymph Node Syndrome | CN | 31 Dec 1997 | |
Purpura, Thrombocytopenic | CN | 31 Dec 1997 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Purpura, Thrombocytopenic, Idiopathic | Phase 3 | CN | 23 Dec 2021 |